- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-tetramer
- Ligands
- 10 x 6OU: [(2~{R})-1-[2-azanylethoxy(oxidanyl)phosphoryl]oxy-3-hexadecanoyloxy-propan-2-yl] (~{Z})-octadec-9-enoate(Non-covalent)(Non-functional Binders)
- 10 x EQK: N-[5-[2-(2-cyanopropan-2-yl)pyridin-4-yl]-4-(trifluoromethyl)-1,3-thiazol-2-yl]-4,6-dimethoxy-pyrimidine-5-carboxamide(Non-covalent)
EQK.2: 18 residues within 4Å:- Chain A: L.635, T.636, I.637, G.638, V.662, T.665, F.666, L.669
- Chain B: L.635, L.642, I.659, V.662, I.663, F.666
- Chain C: I.637
- Ligands: EQK.3, EQK.11, EQK.12
5 PLIP interactions:3 interactions with chain A, 2 interactions with chain B- Hydrogen bonds: A:T.636, A:T.665
- pi-Stacking: A:F.666
- Hydrophobic interactions: B:L.642, B:V.662
EQK.3: 15 residues within 4Å:- Chain A: I.663, F.666, V.667, L.670
- Chain C: V.587, F.590, Y.594, T.636, I.637, L.669, M.672, L.676
- Ligands: EQK.2, EQK.12, EQK.19
6 PLIP interactions:3 interactions with chain A, 3 interactions with chain C- Hydrophobic interactions: A:F.666, A:L.670, C:V.587, C:L.676
- pi-Stacking: A:F.666
- Hydrogen bonds: C:T.636
EQK.6: 15 residues within 4Å:- Chain A: L.553, A.556, L.557, W.559, A.560, M.572
- Chain B: V.596, F.597, G.600, F.601, F.656, T.660, I.663, L.664
- Ligands: 6OU.7
5 PLIP interactions:4 interactions with chain B, 1 interactions with chain A- Hydrophobic interactions: B:F.601, B:T.660, B:I.663, B:L.664, A:W.559
EQK.10: 14 residues within 4Å:- Chain B: F.666, L.669, L.670, L.673
- Chain C: I.663, F.666, V.667
- Chain D: F.666, L.669, L.670, L.673, L.676
- Ligands: EQK.11, EQK.19
4 PLIP interactions:4 interactions with chain C- Hydrophobic interactions: C:I.663, C:F.666, C:V.667
- pi-Stacking: C:F.666
EQK.11: 15 residues within 4Å:- Chain B: V.587, F.590, T.636, I.637, G.638, L.669, L.673, L.676
- Chain D: I.663, F.666, V.667, L.670
- Ligands: EQK.2, EQK.10, EQK.19
6 PLIP interactions:3 interactions with chain B, 3 interactions with chain D- Hydrophobic interactions: B:V.587, B:L.676, D:F.666, D:L.670
- Hydrogen bonds: B:T.636
- pi-Stacking: D:F.666
EQK.12: 14 residues within 4Å:- Chain A: F.666, L.669, L.670, M.672, L.673
- Chain B: I.663, F.666, V.667
- Chain C: F.666, L.669, L.670, L.673
- Ligands: EQK.2, EQK.3
3 PLIP interactions:3 interactions with chain B- Hydrophobic interactions: B:I.663, B:V.667
- pi-Stacking: B:F.666
EQK.13: 15 residues within 4Å:- Chain A: V.596, F.597, G.600, F.601, F.656, T.660, L.664
- Chain C: L.553, A.556, L.557, W.559, A.560, I.583, L.588
- Ligands: 6OU.5
6 PLIP interactions:3 interactions with chain C, 3 interactions with chain A- Hydrophobic interactions: C:W.559, C:I.583, A:F.601, A:F.656, A:T.660
- Hydrogen bonds: C:A.556
EQK.16: 15 residues within 4Å:- Chain C: V.596, F.597, G.600, F.601, F.656, T.660, I.663, L.664
- Chain D: L.553, A.556, L.557, W.559, A.560, M.572
- Ligands: 6OU.14
5 PLIP interactions:1 interactions with chain D, 4 interactions with chain C- Hydrophobic interactions: D:W.559, C:F.601, C:T.660, C:I.663, C:L.664
EQK.17: 14 residues within 4Å:- Chain B: L.553, A.556, L.557, W.559, A.560, L.588
- Chain D: V.596, F.597, G.600, F.601, F.656, T.660, L.664
- Ligands: 6OU.8
6 PLIP interactions:3 interactions with chain D, 3 interactions with chain B- Hydrophobic interactions: D:F.601, D:T.660, D:L.664, B:W.559, B:L.588
- Hydrogen bonds: B:A.556
EQK.19: 18 residues within 4Å:- Chain B: I.637
- Chain C: L.635, L.642, I.659, V.662, I.663, F.666
- Chain D: L.635, T.636, I.637, G.638, V.662, T.665, F.666, L.669
- Ligands: EQK.3, EQK.10, EQK.11
5 PLIP interactions:3 interactions with chain D, 2 interactions with chain C- Hydrogen bonds: D:T.636, D:T.665
- pi-Stacking: D:F.666
- Hydrophobic interactions: C:L.642, C:V.662
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Fan, J. et al., Structural basis of TRPV3 inhibition by an antagonist. Nat.Chem.Biol. (2023)
- Release Date
- 2022-11-09
- Peptides
- Fusion protein of Transient receptor potential cation channel subfamily V member 3 and 3C-GFP: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
BB
CC
AD
D - Membrane
-
We predict this structure to be a membrane protein.
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-tetramer
- Ligands
- 10 x 6OU: [(2~{R})-1-[2-azanylethoxy(oxidanyl)phosphoryl]oxy-3-hexadecanoyloxy-propan-2-yl] (~{Z})-octadec-9-enoate(Non-covalent)(Non-functional Binders)
- 10 x EQK: N-[5-[2-(2-cyanopropan-2-yl)pyridin-4-yl]-4-(trifluoromethyl)-1,3-thiazol-2-yl]-4,6-dimethoxy-pyrimidine-5-carboxamide(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Fan, J. et al., Structural basis of TRPV3 inhibition by an antagonist. Nat.Chem.Biol. (2023)
- Release Date
- 2022-11-09
- Peptides
- Fusion protein of Transient receptor potential cation channel subfamily V member 3 and 3C-GFP: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
BB
CC
AD
D - Membrane
-
We predict this structure to be a membrane protein.